Headache Service Formulary v1.0 Drug Name & Dose Range 1st Line Treatment 2nd Line Treatment 3rd Line Treatment Comments Migraine Acute Treatments Simple analgesia♣ and
lyophilisates 10mg or Zolmitriptan nasal spray
In very severe migraines: Sumatriptan s/c injection 12mg/ml 0.5ml syringe ONLY when oral medication not possible due to vomiting AND Zolmitriptan nasal spray not tolerated
Migraine Prevention All preventative treatments initially start as monotherapy. If side effects to first drug or not response at all then change to second line drug. If some benefit with initial drug but not completely resolved then dual therapy with a second line drug may be appropriate. The choice of preventative medication should be guided by the side effect profile and the patient’s comorbid conditions. Propranolol 80mg-240mg Amitripyline∇ 10mg-
Following are third line use options with stated
Sodium Valporate∇ 400mg-1,500mg daily in
divided doses in if bipolar disorder coexists
Venlafaxine∇ 75mg- 150mg if depression
Gabapentin∇ 300mg daily initially increasing
according to response upto 2400mg daily in
three divided doses if neuropathic pain/ muscle
♣ Simple analgesia: Ibuprofen 400mg 4-6 hourly prn or Paracetamol 1000mg 4-6 hourly prn or Aspirin 600-900mg dispersible 4-6 hourly prn or Naproxen∇ 500mg-1000mg bd ♦ Antiemetics: Metoclopramide 10mg tds or Prochlorperazine 10mg 2-3 times daily PRN or Domperidone 10-20mg 3-4 times daily ∇ Unlicensed indication
Headache Service Formulary MMC Approved Dec 2011
Chronic Tension Type Headaches Acute Treatments Chronic Tension Type Headaches Prevention All preventative treatments initially start as monotherapy. If side effects to first drug or not response at all then change to second line drug. If some benefit with initial drug but not completely resolved then dual therapy with a second line drug may be appropriate. The choice of preventative medication should be guided by the side effect profile and the patient’s comorbid conditions. Stop overuse of Cluster Headaches Acute Treatments
Zolmitriptan∇ nasal spray 5mg/0.1ml used if
Prednisolone∇ 60-100mg once daily for 2-5 days
can be used if preventative therapy starting. NB:
dose reduction to occur after 2-5days in 10mg
Cluster Headaches Prevention All preventative treatments initially start as monotherapy. If side effects to first drug or not response at all then change to second line drug. If some benefit with initial drug but not completely resolved then dual therapy with a second line drug may be appropriate. The choice of preventative medication should be guided by the side effect profile and the patient’s comorbid conditions.
ECG needed if doses more than 480mg daily
Headache Service Formulary MMC Approved Dec 2011
Paroxysmal Hemicrania/ Hemicrania continua Indometacin∇ upto References Scottish Intercollegiate Guideline Network. National Clinical Guideline 107. Diagnosis and Management of Headaches in Adults. Nov 2008 British Association for the Study of Headache. Guidelines for All Healthcare Professionals in the Diagnosis and Management of Migraine, Tension-Type Headache, Cluster Headache and Medication-Overuse Headache. 3rd edition 2010.
Date Developed: November 2011 Date Ratified by NHS Lambeth Medicines Management Committee: December 2011 Date of Review: June 2012
Headache Service Formulary MMC Approved Dec 2011
British Journal of Nutrition (2005), 93, 281–289Additional protein intake limits weight regain after weight loss in humansManuela P. G. M. Lejeune*, Eva M. R. Kovacs and Margriet S. Westerterp-PlantengaDepartment of Human Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands(Received 28 January 2004 – Revised 7 July 2004 – Accepted 21 September 2004)Since lon
Questioning the Global Warming Science: An Annotated bibliography of recent peer-reviewed papers (Short Version) Prepared By Madhav L Khandekar Environmental Consultant FRIENDS OF SCIENCE Calgary, Alberta January 2007 Scope & Purpose of the Document This Document presents an annotated bibliography of selected peer-reviewed papers whichquestion the current state of